Jim Cramer Blog

Symbol
Name
Last Trade
Change
Volume
Related Info
IMH
IMPAC MTG HLDGS INC
4.53 2:07PM ET
1.33 (22.70%)
4,403,400
NUVO
NUVELO INC NEW
2.71 2:11PM ET
0.63 (18.86%)
5,451,350

NVH
NATL RV HLDGS INC
1.54 1:59PM ET
0.26 (14.44%)
41,800

IOC
INTEROIL CORP
25.50 2:07PM ET
4.83 (15.92%)
6,812,700
WHI
W HOLDING CO INC
2.63 2:07PM ET
0.49 (15.71%)
4,728,100
HRLY
HERLEY INDS INC
15.50 2:10PM ET
2.33 (13.07%)
694,804

OMTL
OMTOOL LTD
1.73 12:59PM ET
0.21 (10.82%)
2,702

ASPV
ASPREVA PHARMACEUTIC
16.85 2:12PM ET
2.18 (11.46%)
3,779,437

AUSA
ACCESS PLANS USA INC
1.6980 10:22AM ET
0.2020 (10.63%)
175
PKE
PARK ELECTROCHEMICAL
28.34 2:07PM ET
3.21 (10.17%)
672,800
FREEZ
FREESEAS INC WT Z
2.26 1:56PM ET
0.24 (9.60%)
3,225

THLD
THRESHOLD PHARMACEUT
1.21 2:06PM ET
0.17 (12.10%)
446,780

CORT
CORCEPT THERAPEUTICS
2.65 2:10PM ET
0.19 (6.69%)
296,645

FREEW
FREESEAS INC
2.25 1:14PM ET
0.23 (9.27%)
15,456

BKCC
BLACKROCK KELSO CAPI
14.55 2:11PM ET
1.45 (9.06%)
3,623,332

DLPX
DELPHAX TECH INC
1.11 2:10PM ET
0.11 (9.02%)
8,226

HOTJ
HOUSE OF TAYLR JEWLR
1.26 2:11PM ET
0.10 (7.35%)
77,900

CNIC
COPERNIC INC
2.60 2:11PM ET
0.25 (8.77%)
516,028
FAVS
FIRST AVIATION SVCS
2.44 9:46AM ET
0.23 (8.61%)
200

NEOL
NEOPHARM INC
1.13 2:12PM ET
0.11 (8.50%)
304,278

Labels: ASPV, AUSA, BKCC, CNIC, CORT, DLPX, FAVS, FREEW, FREEZ, HOTJ, HRLY, IMH, IOC, NEOL, NUVO, NVH, OMTL, PKE, THLD, WHI

Symbol
Name
Last Trade
Change
Volume
Related Info
BLTI
BIOLASE TECH INCS3
8.32 2:11PM ET
1.78 (17.62%)
1,188,311

NUVO
NUVELO INC NEW
4.48 2:11PM ET
0.92 (17.04%)
24,536,618

AMMD
AMER MED SYS HLDG
18.04 2:11PM ET
3.39 (15.82%)
8,496,599

SBN
SOFTBRANDS INC
1.81 2:01PM ET
0.37 (16.97%)
351,100

METH
METHODE ELECTR
13.51 2:11PM ET
2.38 (14.98%)
848,883

HAQ-WT
HEALTHCARE ACQ WTS
1.03 12:24PM ET
0.17 (14.17%)
6,300

CAW
C C A INDS INC
10.35 1:59PM ET
1.58 (13.24%)
181,100

DNDN
DENDREON CORP
18.9164 2:11PM ET
3.2336 (14.60%)
39,460,865

NTBK
NET.BANK INC
1.56 2:10PM ET
0.19 (10.86%)
658,562

KMA
KMG AMERICA CORP
5.07 2:04PM ET
0.07 (1.36%)
30,800

TSTF
TEAMSTAFF INC
1.01 2:11PM ET
0.14 (12.17%)
46,092

JOB
GEN EMPLOYMENT ENTER
2.8701 1:51PM ET
0.3599 (11.14%)
212,200
CEGE
CELL GENESYS INC
5.42 2:11PM ET
0.66 (10.86%)
11,438,332

MIND
MITCHAM INDS INC
14.22 2:11PM ET
1.72 (10.79%)
1,083,022

WRSP
WORLDSPACE INC
3.29 2:07PM ET
0.35 (9.62%)
79,941

NRMX
NEUROCHEM INC
13.40 2:10PM ET
1.60 (10.67%)
2,087,206

REX
VIREXX MEDICAL INC
0.95 2:03PM ET
0.06 (5.94%)
127,400

GPTX
GLOBAL PAYMENT TEC
1.12 11:35AM ET
0.12 (9.68%)
300

EZEM
EZ EM INC
15.03 2:08PM ET
1.57 (9.46%)
309,842

BTJ
BOLT TECHNOLOGY
36.34 2:06PM ET
3.05 (7.74%)
824,800

FREEZ
FREESEAS INC WT Z
1.01 9:49AM ET
0.10 (9.01%)
300

Labels: AMMD, BLTI, BTJ, CAW, CEGE, DNDN, EZEM, FREEZ, GPTX, JOB, KMA, METH, MIND, NRMX, NTBK, NUVO, REX, SBN, TSTF, WRSP

The volatility of the first quarter that ended Friday, was reflected in several stocks that saw unusual activity during the week, including a drop for Boston Scientific and a jump for Abbott Laboratories.
Boston Scientific Corp. slid 6.6 percent Monday after a study showed a heart stent made by Abbott had lower rates of target vessel failure. This means the drug-coated stent performed better than Boston Scientific's Taxus.
The study was originally meant to show that the Abbott stent, called Xience, was merely not inferior to Taxus. Both stocks traded with very heavy volume, and sent shares of other stent makers into accelerated trading as well.
Shares of Boston Scientific sank to a nearly five-year low of $13.88 on the news, with volume approaching three times its typical trade of about 12 million shares. The New York Stock Exchange-listed shares recovered slightly as the week continued as volume returned to more normal levels, ending the week at $14.54.
Meanwhile, Abbott shares on Monday gained 6 percent and hit an all-time high of $57.26, with trading volume almost four times a typical day. Volume remained high Tuesday as shares began to slip a bit, and by Friday the stock settled back to close at $55.80, still up 3.6 percent for the week.
Nuvelo Inc. shot up 25 percent Tuesday to $3.86, after the smallcap company said the Food and Drug Administration has granted "fast-track" status to its colon cancer drug candidate as both a first- and second-line treatment.
That means Nuvelo can submit data to the FDA on a rolling basis rather than all at once, speeding up the application process.
Trading volume jumped to about 9 times its usual volume, with 28 million shares changing hands on the Nasdaq Stock Market. Activity remained high Wednesday, though volatility leveled out. The stock gave back some of its Tuesday gains but ended the week up 19 percent at $3.68.
On Wednesday, Beazer Homes USA Inc. plunged more than 8 percent to $28.77 on the NYSE, after the FBI said it is among agencies investigating possible fraud in the company's mortgage lending practices and other financial transactions.
The homebuilder said it was cooperating with a federal prosecutor's request for documents. The news came on top of ongoing struggles for the Atlanta-based company, which has suffered hefty losses amid a downturn in the housing market.
Trading volume swelled to 19.6 million shares changing hands, from a typical level of 1.6 million shares.
The U.S. attorney's office in Charlotte, N.C., along with the Internal Revenue Service and the U.S. Department of Housing and Urban Development are also participating in the investigation.
Volume settled back down the rest of the week, though the stock didn't recoup much of the loss. Shares of Beazer ended the week down 7.6 percent at $29.03.
RF Micro Devices Inc., which makes components used in mobile phones, on Thursday shed 11 percent to end at $6.31 on the Nasdaq, after the company projected a first-quarter slowdown. Trading volume zoomed to 63.3 million shares, from a usual 8.7 million shares changing hands.
The news prompted a Jefferies analyst to downgrade the stock. The company blamed lighter demand from a top customer, but did not provide more details. Analysts suspect the customer is mobile phone maker Motorola Inc., which recently warned of a more than $1 billion expected sales miss.
Shares lost another 8 cents Friday, with volume nearing 40.6 million shares, to close the week at $6.23.
Friday, Dendreon Corp. more than doubled its share price with extraordinarily heavy trading volume, surging $7.71 to $12.93 on the Nasdaq, and during the session spiked to $18.05, its highest point since December 2000. Volume approached 92.5 million shares, more than the 75.7 million shares the company had outstanding
The drug maker said a Food and Drug Administration panel endorsed its experimental prostate cancer vaccine, Provenge. The FDA advisers said the vaccine is safe, and said there is substantial evidence that it works in treating advanced prostate cancer that no longer responds to hormone treatment. The drug needs further study before it can be approved.
Published By AP

Labels: ABT, BSX, BZH, DNDN, MOT, NUVO, RFMD

Symbol
Name
Last Trade
Change
Volume
Related Info
NUVO
NUVELO INC NEW
3.8896 11:17AM ET
0.7996 (25.88%)
15,401,227
Chart, Profile, More
CIMT
CIMATRON ORD SHS
3.242 11:16AM ET
0.622 (23.74%)
406,095
Chart, Profile, More
ARUN
ARUBA NETWORKS, INC.
11.00 Dec 31
0.00 (0.00%)
0
Chart, , More
CVTX
CV THERAPEUTICS I
8.1055 11:17AM ET
1.3555 (20.08%)
5,769,784
Chart, Profile, More
PLX
PROTALIX BIOTHERAPEU
29.50 11:02AM ET
4.02 (15.78%)
4,700
Chart, , More
DMC
DOCUMENT SECURTY SYS
9.4001 11:12AM ET
0.8001 (9.30%)
71,300
Chart, Profile, More
VHI
VALHI INC
13.71 11:12AM ET
1.90 (16.09%)
196,800
Chart, Profile, More
FCEL
FUELCELL ENERGY IN
8.35 11:17AM ET
1.15 (15.97%)
8,366,958
Chart, Profile, More
BDR
BLONDER TONGUE
2.08 11:09AM ET
0.24 (13.04%)
55,200
Chart, Profile, More
IOT
INCOME OP RL INV INC
6.25 9:39AM ET
0.62 (11.01%)
500
Chart, Profile, More
GME
GAMESTOP CORP
31.23 11:12AM ET
3.26 (11.66%)
5,070,323
Chart, Profile, More
REGN
REGENERON PHARMACE
21.17 11:17AM ET
2.02 (10.55%)
1,589,788
Chart, Profile, More
CSLR
CONSULIER ENGR INC
5.15 11:07AM ET
0.43 (9.11%)
4,777
Chart, Profile, More
ROHI
ROTECH HEALTHCARE
1.96 11:15AM ET
0.22 (12.64%)
239,871
Chart, Profile, More
COHT
COHESANT TECH INC
7.481 10:44AM ET
0.581 (8.42%)
7,482
Chart, Profile, More
AKRX
AKORN INC
6.45 11:13AM ET
0.48 (8.04%)
486,340
Chart, , More
LMLP
LML PAYMENT SYST
3.5299 11:16AM ET
0.26 (7.95%)
23,490
Chart, Profile, More
SLI
S L INDUSTRIES INC
14.1399 10:29AM ET
1.1899 (9.19%)
7,700
Chart, Profile, More
BTRX
BARRIER THERAPEUTICS
6.47 11:15AM ET
0.30 (4.86%)
190,307
Chart, Profile, More
CHRK
CHEROKEE INTL CP
5.84 11:16AM ET
0.41 (7.55%)
52,700
Chart, Profile, More

Labels: AKRX, ARUN, BDR, BTRX, CHRK, CIMT, COHT, CSLR, CVTX, DMC, FCEL, GME, IOT, LMLP, NUVO, PLX, REGN, ROHI, SLI, VHI

The trading week started with the major indexes rising, but the news wasn't positive for Nuvelo Inc.
Shares of the San Carlos, Calif., biotech drug maker plunged Monday after two trials of a blood thinner drug it was developing with Bayer HealthCare failed, and the companies suspended a second study.
Nuvelo shares plummeted as much as 82 percent after the news broke, bottoming out at a 52-week low of $3.35, after closing on the Nasdaq the previous Friday at $19.55. Shares recovered a bit, to close the session at $4.05, still down more than 79 percent on the session. Volume of more than 90 million shares was more than 176 times normal daily trading in the shares.
Shares continued to trade heavily through the rest of the week, with more than 33 million shares changing hands Tuesday and about half that Wednesday. The stock did not recover from Monday's blow, however, edging up just slightly to close the week at $4.16.
Tuesday, microcap Internet search engine Mamma.com caught investors' eyes, when it introduced a new video search function that offers features not found even on Google.com.
Shares of the Montreal-based company soared 80.6 percent to close at $4.28 on the Nasdaq, while volume surged to nearly 30 million shares, about 25 times normal trading. Shares closed Monday at $2.37.
The rally continued Wednesday as share gained as much as 10 percent before settling back down, as volume remained extraordinary. After edging back Thursday, the exuberance for Mamma.com shares returned to end the week with shares hitting a new 52-week high of $5.28, a 30 percent gain, before giving up some of the surge to end up 9.6 percent at $4.44. Volume again topped 26 million.
For the week, Mamma.com shares gained 87 percent.
Wednesday, news and rumors of industry consolidation sent airline shares flying high, with Midwest Air Group Inc. getting the biggest lift, after the Oak Creek, Wis. regional carrier received a hostile takeover bid from AirTran Holdings Inc.
Midwest rejected the $290 buyout offer, but AirTran said it won't give up its quest.
That was enough for investors to keep the shares aloft. After spiking up almost 28 percent, shares edged backed a bit to close Wednesday up $1.30, or 22.2 percent, at $11.10, from their prior day close at 9.08. Trading topped 2 million shares, more than 7 times normal daily volume.
Shares continued to trade heavily and gained 8.6 percent Thursday, but gave up some of the gain even as trading volume ebbed in Friday's session. Nevertheless, shares were up 29 percent since AirTran made its bid, closing the week at $11.72.
Thursday it was more takeover talk, as shares of Worthington Industries Inc. shot up on speculation the metal processing company may be a buyout target. There was no bid for the Columbus, Ohio, company, but at least one analyst said it would be an attractive buy in a consolidating industry.
The stock leaped as high as $21.36 before retreating a bit, to end the session up $2.02, or 11 percent, at $20.32 from their close Wednesday at $18.30. Volume was nearly seven times normal daily trading.
Trading remained about twice as heavy as normal Friday, a share gained 10 cents more to close the week at $20.42.
And Friday, Weyerhaeuser Co., gained nearly 4 percent from their prior day close of $69.49, in trading more than nine times normal, after the lumber and paper producer was upgraded to "Buy," by Deutsche Bank following an announcement it would close one sawmill in Washington and build a newer, more efficient plant.
The move was seen as part of a needed effort to revamp the Federal Way, Wash., company's operations.
Shares gained $2.44, or 3.5 percent, to close at $71.93 on the New York Stock Exchange, after matching their 52-week high of $75.50 earlier in the session, on volume of 14.5 million shares.

Labels: AAI, DB, MAMA, MEH, NUVO, WOR, WY

Beckman Coulter (NYSE:BEC - News) said it plans to sell $525 million worth of convertible debt, due 2036. The Fullerton, Calif. biomedical systems maker expects to grant the underwriters of the convertible debt option to buy up to an additional $75 million to cover over-allotments. Concurrently, the company said it would launch a 2.5 million share buyback program. The company said it would use the proceeds from the convertible debt sale to repurchase $100 million worth of its common stock.
Brookfield Properties Corp. (NYSE:BPO - News) plans to sell 30 million shares to investors. Brookfield Asset Management, which owns 51% of Brookfield Properties, will purchase around 11.25 million shares. Brookfield Properties will use the offer proceeds to repay outstanding debt and for general corporate purposes. Merrill Lynch, Pierce, Fenner & Smith Inc. and J.P. Morgan Securities will act as joint book-running managers and underwriters for the proposed offering. Separately, Brookfield Properties said that it's expecting to report 2007 funds from operations per share in a range of $2.10 to $2.20, reflecting up to 17% growth over the mid-point of 2006 guidance.
Devon Energy (NYSE:DVN - News) said Brian Jennings has left the company's chief financial officer position. The company said the departure is "in no way related to any issues regarding financial disclosures, accounting matters or other business issues."
Diodes Inc. (NASDAQ:DIOD - News) was downgraded to neutral from buy at UBS, citing valuation and concerns about moderating growth. The firm lowered its price target to $45 from $52.
Eaton Corp. (NYSE:ETN - News) was downgraded to neutral from outperform at Credit Suisse.
Hubbell Inc. (NYSE:HUB-A - News) (NYSE:HUB-B - News) cut its estimate of 2006 earnings to $2.53 to $2.58 a share. The Orange, Conn., company said it also cut its 2006 sales estimate to $40 million. Hubbell said it is seeing lower volumes in several of its key markets and the pace and depth of the decline has accelerated more rapidly than expected in the fourth quarter.
Memory Pharmaceuticals Corp. (NASDAQ:MEMY - News) plans begin the Phase IIa clinical trial for MEM 3454, a potential treatment for Alzheimer's disease, in the first quarter after the U.S. Food and Drug Administration released its clinical hold on development of the drug. The FDA, which had put development of the drug on hold in October, has now completed its review of Memory's investigational new-drug application, Memory said.
Nuvelo Inc. (NASDAQ:NUVO - News) and Bayer AG (NYSE:BAY - News) said a Phase III clinical trial of alfimeprase in acute peripheral arterial occlusion didn't meet its primary endpoint of avoidance of open vascular surgery within 30 days of treatment. The Phase 3 trial in catheter occlusion didn't meet the endpoint of restoration of function within 15 minutes. These trials did not meet key secondary endpoints, they added. Further, they have temporarily suspended enrollment in the ongoing Phase 3 NAPA-3 and SONOMA-3, until further analyses and discussions with outside experts and regulatory agencies are completed.
Parker-Hannifin Corp. (NYSE:PH - News) was downgraded to neutral from outperform at Credit Suisse. The firm cited softening end markets and weaker North America business.
Steel Dynamics (NASDAQ:STLD - News) was downgraded to neutral from buy at UBS citing valuation.
Synergetics USA Inc. (NASDAQ:SURG - News) reported fiscal first-quarter net earnings of $377,000, or 2 cents a share, down from $486,000, or 4 cents a share, in the year-ago period. There were 24.4 million shares outstanding in the quarter, compared with 11.9 million in the same period last year.
UnionBanCal Corp. (NYSE:UB - News) said its main subsidiary, Union Bank of California, will receive a tax refund and interest from the State of California totaling $113.7 million, or $72.6 million after taxes. The settlement is for recovery of taxes paid between 1989 and 1995.
VeraSun Energy (NYSE:VSE - News) shares slid after the company said Friday that Donal Endres, its chairman and CEO, has established a pre-arranged trading plan to sell a portion of his stock holdings.

Labels: BAY, BEC, BPO, DIOD, DVN, ETN, Hot Stocks, HUB, MEMY, NUVO, PH, STLD, SURG, UB, VSE

Biotech drug maker Nuvelo Inc. and partner Bayer HealthCare said Monday that two clinical trials for their blood thinner candidate failed, and the companies placed another study on hold in the meantime.
Shares of Nuvelo dropped $15.80, or 80.8 percent, to $3.75 in premarket activity on the INET electronic exchange, after closing Friday at $19.55 on the Nasdaq. Shares have traded between $7.93 and $20.98 over the past 52 weeks.
Bayer HealthCare is a unit of German drug maker Bayer AG.
In one late-stage clinical trial, the drug, known as alfimeprase, failed to keep patients with blockages in their peripheral arteries from needing surgery after 30 days of treatment.
Another study, where the drug was intended to clear patients' clogged catheters in 15 minutes, also failed.

Labels: Nuvelo Inc., NUVO